Found 248 matching trials
Analysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer PHASE2 This is a multicenter single-arm phase II clinical trial to evaluate the ef...
Show More Location
Hospital Universitario Germans Trias i Pujol
Learn More & Join Trial
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION) PHASE2 Researchers are looking for other ways to treat pulmonary arterial hyperten...
Show More Status
Active Not Recruiting
Location
University of Colorado Anschutz Medical Campus-University of Colorado Hospital Cardiac and Vascular ( Site 1930)
Learn More & Join Trial
Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast Cancer PHASE2 Triple-negative breast cancer (TNBC) is a special type of breast cancer, en...
Show More Location
Guangdong general hospital
Learn More & Join Trial
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events PHASE2 The purpose of this study is to identify preventive treatments that can min...
Show More Location
University of California San Francisco
Learn More & Join Trial
Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children PHASE2 A two-arm, Phase 2/3 multicentre, open-label, randomised study evaluating s...
Show More Location
Hospital Garrahan
Learn More & Join Trial
A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread PHASE1 The purpose of this study is to determine whether a combination of Nivoluma...
Show More Location
Pacific Shores Medical Group
Learn More & Join Trial
Safety, Pharmacokinetics (PK) of AKT and MEK Combination PHASE1 This study is a Phase 1 dose-escalation open-label study to determine the r...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Metabolic Flexibility in Patients With Early Triple-negative Breast Cancer NA Cancer is considered a major global public health problem. It was estimated...
Show More Status
Active Not Recruiting
Location
Universidad Europea de Madrid, Villaviciosa de Odón
Learn More & Join Trial
Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast Cancer PHASE1 This pilot phase I trial studies whether it is feasible to conduct a detail...
Show More Location
OHSU Knight Cancer Institute
Learn More & Join Trial
NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast Cancer PHASE3 TNBC is a heterogeneous disease with distinct pathological, genetic, and cl...
Show More Location
SLK-Kliniken Heilbronn GmbH, Klinik für Gynäkologie und Geburtshilfe
Learn More & Join Trial